Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the Relay®Pro Thoracic Stent-Graft device for the treatment of dissection and transection in the United States. Relay®Pro delivers uncompromised clinical performance in the lowest commercially available profile and is indicated for all pathologies of the descending thoracic artery; aneurysm,

Terumo Aortic today announced the first North American implant of a novel custom-made hybrid device, Thoracoflo™, which is used to treat patients with thoracoabdominal aortic disease using a less invasive surgical technique than traditional open surgical repair. This thoracoabdominal repair procedure using Thoracoflo™ was carried out by Dr Randy Moore, Co-Director of the Calgary Complex

Terumo Aortic today announced that the United States Centers for Medicare and Medicaid Services (CMS) has granted approval of a New Technology Add-on Payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid Device under the Inpatient Prospective Payment System (IPPS). Thoraflex Hybrid is the first of its kind device used in Frozen Elephant Trunk (FET) repair in